| Literature DB >> 34532834 |
Yuan-Yuan Lei1, Suzanne C Ho2, Carol Kwok3, Ashley Cheng3, Ka Li Cheung1, Roselle Lee1, Frankie K F Mo1,4, Winnie Yeo5,6.
Abstract
PURPOSE: Dietary intake and patients' quality of life (QoL) are important supportive care issues in breast cancer survivorship. This study aimed to identify dietary pattern before and after breast cancer diagnosis. In addition, the association between dietary patterns and QoL were cross-sectionally and longitudinally investigated.Entities:
Keywords: Breast cancer; Chinese women; Dietary pattern; Quality of life
Mesh:
Year: 2021 PMID: 34532834 PMCID: PMC9023405 DOI: 10.1007/s11136-021-02985-0
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 3.440
Representative food groupsa for the two major dietary patterns identified by principal component analysis at 18-month follow-up
| Foods/food groups | Factor 1 Grain and animal food pattern | Factor 2 Vegetable and fruit pattern |
|---|---|---|
| Refined grain | 0.722 | |
| Red meat | 0.478 | |
| Fish and seafood | 0.411 | |
| Oil | 0.408 | |
| Cakes and snacks | 0.302 | |
| Processed meat | 0.266 | |
| Eggs | 0.262 | |
| Leaf vegetables | 0.932 | |
| Other vegetables | 0.489 | |
| Fruits | 0.390 | |
| Potato | 0.314 | |
| Legumes | 0.281 | |
| Variance explained (%) | 26.228 | 12.154 |
aRepresentative food groups were selected based on factor loadings > 0.25
Characteristics of patients according to the tertiles of factor scores of each dietary pattern at 18-month follow-up
| Grain and animal food pattern | Vegetables and fruits pattern | |||||||
|---|---|---|---|---|---|---|---|---|
| Tertile 1 | Tertile 2 | Tertile 3 | Tertile 1 | Tertile 2 | Tertile 3 | |||
| Number of patients | 408 | 410 | 408 | 409 | 409 | 408 | ||
| Factor score, median (range) | − 0.9 (-3.4 to -0.5) | − 0.1 (-0.5 to 0.3) | 0.9 (0.3 to 5.1) | − 0.9 (-2.1 to − 0.5) | − 0.2 (− 0.5 to 0.3) | 0.8 (0.3 to 5.3) | ||
| Follow-up time since diagnosis, months, mean (SD) | 19.1 (3.6) | 19.2 (3.4) | 19.5 (3.9) | 0.219 | 19.3 (3.5) | 19.1 (3.4) | 19.6 (3.9) | 0.135 |
| Age at follow-up, years, mean (SD) | 55.0 (9.2) | 54.1 (8.8) | 52.4 (8.9) | 54.4 (9.3) | 53.5 (9.3) | 53.6 (8.5) | 0.260 | |
| Education level, % | 0.269 | 0.018 | ||||||
| High school or below | 83.6 | 87.6 | 85.5 | 88.3 | 86.8 | 81.6 | ||
| Collage or above | 16.4 | 12.4 | 14.5 | 11.7 | 13.2 | 18.4 | ||
| Marital status, % | ||||||||
| Married or cohabitation | 67.9 | 75.9 | 68.7 | 66.7 | 74.8 | 70.6 | ||
| Unmarried or divorced | 32.1 | 24.1 | 32.3 | 33.3 | 25.5 | 29.4 | ||
| Household income (HKD/month), % | 0.900 | |||||||
| < 15,000 | 48.0 | 47.8 | 45.1 | 49.6 | 41.3 | 50.0 | ||
| 15,000–30,000 | 30.4 | 31.5 | 33.1 | 32.8 | 31.8 | 30.4 | ||
| ≥ 30,000 | 21.6 | 20.7 | 21.8 | 12.6 | 26.9 | 19.6 | ||
| BMI at follow-up, kg/m2, % | 0.450 | |||||||
| Underweight (< 18.5) | 6.1 | 4.6 | 4.9 | 4.4 | 8.3 | 2.9 | ||
| Normal (18.5–22.9) | 48.0 | 44.9 | 43.9 | 44.7 | 41.6 | 50.5 | ||
| Overweight (23–24.9) | 20.3 | 22.4 | 19.4 | 20.5 | 20.5 | 21.1 | ||
| Obese (≥ 25) | 23.5 | 28.0 | 31.9 | 30.3 | 29.6 | 25.5 | ||
| Number of comorbidities, % | 0.056 | 0.094 | ||||||
| None | 57.8 | 60.5 | 64.7 | 57.9 | 62.3 | 62.7 | ||
| 1 | 25.5 | 26.8 | 25.5 | 25.9 | 24.4 | 27.5 | ||
| ≥ 2 | 16.7 | 12.7 | 9.8 | 16.1 | 13.3 | 9.8 | ||
| Parity, % | 0.916 | 0.212 | ||||||
| 0 | 22.1 | 20.7 | 24.3 | 22.2 | 19.5 | 25.2 | ||
| 1 | 22.8 | 22.7 | 23.0 | 22.0 | 25.2 | 21.3 | ||
| 2 | 36.8 | 39.0 | 35.8 | 35.8 | 37.2 | 38.8 | ||
| ≥ 3 | 18.4 | 17.6 | 16.9 | 20.0 | 18.1 | 14.7 | ||
| Menopause status at follow-up, % | 0.609 | |||||||
| Pre-menopausal | 18.4 | 16.6 | 24.3 | 79.5 | 79.5 | 81.9 | ||
| Post-menopausal | 81.6 | 83.4 | 75.7 | 20.5 | 20.5 | 18.1 | ||
| AJCC stage at diagnosis | 0.056 | 0.533 | ||||||
| I | 33.1 | 30.2 | 31.4 | 30.1 | 32.5 | 32.1 | ||
| II | 51.4 | 48.8 | 44.4 | 50.6 | 46.2 | 47.8 | ||
| III | 15.5 | 20.3 | 24.0 | 18.6 | 21.3 | 19.4 | ||
| I–III without detail | 0.5 | 0.7 | 0.2 | 0.7 | 0 | 0.7 | ||
| Histology, % | 0.668 | 0.798 | ||||||
| IDC | 90.0 | 90.0 | 89.0 | 89.0 | 90.5 | 89.5 | ||
| ILC | 2.2 | 3.7 | 3.4 | 3.9 | 2.7 | 2.7 | ||
| Others | 7.8 | 6.3 | 7.6 | 7.1 | 6.8 | 7.8 | ||
| ER status, % | 0.204 | |||||||
| Positive | 75.2 | 74.6 | 70.9 | 71.6 | 77.2 | 71.8 | ||
| Negative | 23.3 | 22.9 | 25.2 | 24.2 | 21.8 | 25.5 | ||
| Missing | 1.5 | 2.4 | 3.9 | 4.2 | 1.0 | 2.7 | ||
| PR status, % | 0.397 | |||||||
| Positive | 56.6 | 59.1 | 53.7 | 55.7 | 57.9 | 55.6 | ||
| Negative | 41.2 | 38.0 | 42.4 | 39.1 | 41.1 | 41.4 | ||
| Missing | 2.2 | 2.9 | 3.9 | 5.1 | 1.0 | 2.9 | ||
| HER2 status, % | 0.479 | 0.579 | ||||||
| Positive | 29.9 | 27.1 | 24.5 | 25.7 | 29.1 | 26.7 | ||
| Negative | 66.9 | 70.0 | 71.6 | 70.4 | 67.2 | 70.8 | ||
| Missing | 3.2 | 2.9 | 3.9 | 3.9 | 3.7 | 2.5 | ||
| Type of surgery | 0.949 | 0.596 | ||||||
| Mastectomy | 65.4 | 64.4 | 64.7 | 66.7 | 64.3 | 63.4 | ||
| Conservation | 34.6 | 35.6 | 35.3 | 33.3 | 35.7 | 36.5 | ||
| Chemotherapy, % | 0.062 | 0.666 | ||||||
| Yes | 77.5 | 83.7 | 82.1 | 82.4 | 80.0 | 80.9 | ||
| No | 22.5 | 16.3 | 17.9 | 17.6 | 20.0 | 19.1 | ||
| Radiation therapy, % | 0.141 | 0.476 | ||||||
| Yes | 66.9 | 72.2 | 72.5 | 71.1 | 72.1 | 68.4 | ||
| No | 33.1 | 27.8 | 27.5 | 28.9 | 27.9 | 31.6 | ||
| Hormone therapy, % | 0.108 | 0.579 | ||||||
| Yes | 77.9 | 72.9 | 78.7 | 76.0 | 78.2 | 75.2 | ||
| No | 22.1 | 27.1 | 21.3 | 24.0 | 21.8 | 24.8 | ||
| Physical activity level, MET-hours/week, mean (SD) | 10.9 (12.8) | 10.0 (13.6) | 9.5 (13.6) | 0.314 | 7.5 (11.4) | 10.0 (12.2) | 13.0 (15.5) | |
| Energy intake, kcal/day, mean (SD) | 1083.7 (252.5) | 1314.7 (251.2) | 1686.8 (389.2) | 1155.1 (279.7) | 1354.7 (355.1) | 1575.7 (413.0) | ||
SD standard deviation, HKD Hong Kong dollars, BMI body mass index, AJCC American joint Committee on cancer, IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DCIS ductal carcinoma in situ, ER estrogen receptor, PR progesterone receptor, HER 2 human epidermal-growth-factor receptor 2, MET metabolic equivalent of task
Bold face: P < 0.05
Multivariate linear regression analyses of the factor scores of “grain and animal food pattern” on QoL in Chinese women with early-stage breast cancer at 18-month follow-up
| EORTC QLQ-C30 | Univariate analysis | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| Global health status/QoL | − 0.679 (− 1.664 to − 0.306) | 0.262 | − 0.786 (− 2.255 to 0.682) | 0.551 | 0.825 (− 0.935 to 2.586) | 0.226 |
| Functioning | ||||||
| Physical functioning | − 0.064 (− 0.696 to 0.568) | 0.831 | 0.343 (− 0.602 to 1.287) | 0.555 | 0.886 (− 0.249 to 2.022) | 0.176 |
| Role functioning | − 1.531 (− 2.349 to − 0.712) | 0.012 | − 0.676 (− 1.911 to − 0.559) | 0.326 | − 0.610 (− 2.097 to 0.876) | 0.682 |
| Emotional functioning | − 0.950 (− 2.001 to 0.100) | 0.466 | 0.078 (− 1.493 to 1.648) | 0.978 | 1.099 (− 0.788 to 2.987) | 0.472 |
| Cognitive functioning | 0.031 (− 1.037 to 1.099) | 0.822 | 1.168 (− 0.445 to 2.781) | 0.180 | 1.618 (− 0.323 to 3.559) | 0.104 |
| Social functioning | − 0.696 (− 1.570 to 0.178) | 0.141 | 0.385 (− 0.933 to 1.703) | 0.855 | 0.473 (− 1.113 to 2.060) | 0.745 |
| Symptoms | ||||||
| Fatigue | 0.443 (− 0.664 to 1.550) | 0.440 | − 1.775 (− 3.431 to − 0.119) | 0.044 | − 2.238 (− 4.230 to − 0.245) | |
| Nausea and vomiting | 0.227 (− 1.138 to 0.591) | 0.057 | 0.048 (− 0.499 to 0.594) | 0.654 | − 0.186 (− 0.844 to 0.472) | 0.974 |
| Pain | 0.916 (− 3.373 to 2.204) | 0.163 | − 0.877 (− 2.792 to 1.039) | 0.444 | − 1.209 (− 3.515 to 1.097) | 0.261 |
| Dyspnea | 0.138 (− 0.812 to 1.087) | 0.608 | − 1.438 (− 2.862 to − 0.013) | 0.048 | − 1.986 (− 3.700 to − 0.272) | |
| Insomnia | − 0.493 (− 2.100 to 1.114) | 0.643 | − 1.029 (− 3.467 to 1.049) | 0.803 | − 1.068 (− 4.002 to 1.866) | 0.540 |
| Loss of appetite | 0.043 (− 0.691 to 0.776) | 0.783 | − 0.378 (− 1.486 to 0.729) | 0.847 | − 1.155 (− 2.486 to 0.176) | 0.193 |
| Constipation | 0.043 (− 1.061 to 1.148) | 0.546 | 0.544 (− 1.130 to 2.218) | 0.347 | − 0.296 (− 2.309 to 1.717) | 0.899 |
| Diarrhea | 0.508 (− 0.193 to 1.209) | 0.084 | 0.696 (− 0.349 to 1.742) | 0.144 | − 0.289 (− 1.543 to 0.965) | 0.810 |
| Financial impact | 0.799 (− 0.530 to 2.128) | 0.054 | − 1.632 (− 3.598 to 0.334) | 0.192 | − 1.074 (− 3.440 to 1.292) | 0.281 |
Multivariate linear regressions were used to analyze the association of “grain and animal food pattern” and QoL. QoL items were log10 transformed in multivariate linear regressions, and the β values (95%CI) presented in the table were back-transformed by base 10 exponent to better interpret the results. The potential confounders were introduced in the models using the enter method. Model 1, adjusted for age at 18-month follow-up, education level, income status, total number of comorbidities, menopausal status at 18-month follow-up, AJCC stage, ER status and PR status, current usage of adjuvant hormonal therapy, BMI at 18-month follow-up, level of physical activity, total energy intake; Model 2, further adjusted for factor scores of “vegetables and fruits pattern”
B Unstandardized coefficient of linear regression model, 95%CI 95% confidence interval, QoL quality of life, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, AJCC American joint Committee on cancer, ER estrogen receptor, PR progesterone receptor
Bold face: P < 0.05
Multivariate linear regression analyses of the factor score of “vegetables and fruits pattern” on QoL in Chinese women with early-stage breast cancer at 18-month follow-up
| EORTC QLQ-C30 | Univariate analysis | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| Global health status/QoL | 1.693 (− 0.712 to 2.674) | 0.003 | 1.847 (0.739 to 2.956) | 0.004 | 2.195 (0.862 to 3.529) | |
| Functioning | ||||||
| Physical functioning | 0.487 (− 0.144 to 1.118) | 0.132 | 0.367 (− 0.348 to 1.082) | 0.337 | 0.741 (− 0.120 to 1.601) | 0.121 |
| Role functioning | − 0.259 (− 1.082 to 0.564) | 0.790 | 0.346 (− 0.589 to 1.282) | 0.249 | 0.089 (− 1.037 to 1.215) | 0.465 |
| Emotional functioning | 0.411 (− 0.640 to 1.462) | 0.363 | 0.928 (− 0.261 to 2.116) | 0.305 | 1.391 (− 0.039 to 2.821) | 0.210 |
| Cognitive functioning | − 0.074 (− 1.142 to 0.993) | 0.865 | − 0.069 (− 1.291 to 1.154) | 0.983 | 0.613 (− 0.857 to 2.083) | 0.357 |
| Social functioning | − 0.457 (− 1.332 to 0.417) | 0.327 | − 0.079 (− 1.078 to 0.919) | 0.873 | 0.120 (− 1.082 to 1.322) | 0.754 |
| Symptoms | ||||||
| Fatigue | 0.453 (− 0.653 to 1.560) | 0.873 | 0.313 (− 0.944 to 1.569) | 0.815 | − 0.630 (− 2.139 to 0.879) | 0.102 |
| Nausea and vomiting | − 0.228 (− 0.592 to 0.137) | 0.517 | − 0.240 (− 0.654 to 0.174) | 0.449 | − 0.318 (− 0.816 to 0.180) | 0.542 |
| Pain | 0.321 (− 0.968 to 1.610) | 0.892 | 0.056 (− 1.395 to 1.508) | 0.763 | − 0.453 (− 2.200 to 1.293) | 0.381 |
| Dyspnea | 0.188 (− 0.761 to 1.138) | 0.683 | 0.090 (− 0.991 to 1.171) | 0.959 | − 0.747 (− 2.046 to 0.552) | 0.224 |
| Insomnia | 0.121 (− 1.486 to 1.728) | 0.699 | 0.397 (− 1.450 to 2.244) | 0.641 | − 0.053 (− 2.276 to 2.170) | 0.467 |
| Loss of appetite | − 0.570 (− 1.303 to 0.162) | 0.068 | − 0.571 (− 1.410 to 0.268) | 0.110 | − 1.058 (− 2.066 to − 0.049) | |
| Constipation | − 1.088 (− 2.191 to 0.015) | 0.054 | − 1.020 (− 2.286 to 0.247) | 0.060 | − 1.144 (− 2.669 to 0.381) | 0.102 |
| Diarrhea | − 1.090 (− 1.788 to − 0.391) | 0.004 | − 1.220 (− 2.010 to − 0.431) | 0.003 | − 1.342 (− 2.292 to − 0.392) | |
| Financial impact | 1.636 (0.309 to 2.963) | 0.031 | 1.212 (− 0.277 to 2.702) | 0.463 | 0.760 (− 1.032 to 2.552) | 0.992 |
Multivariate linear regressions were used to analyze the association of “vegetables and fruits pattern” and QoL. QoL items were log10 transformed in multivariate linear regressions, and the β values presented in the table were back-transformed to better interpret the results. The potential confounders were introduced in the models using the enter method. Model 1, adjusted for age at 18-month follow-up, education level, income status, total number of comorbidities, menopausal status at 18-month follow-up, AJCC stage, ER status and PR status, current usage of adjuvant hormonal therapy, BMI at 18-month follow-up, level of physical activity, total energy intake; Model 2, further adjusted for factor scores of “grain and animal food pattern”
B Unstandardized coefficient of linear regression model, 95%CI 95% confidence interval, QoL quality of life, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, AJCC American joint Committee on cancer, ER estrogen receptor, PR progesterone receptor
Bold face: P < 0.05
GEE models to analyze the factor scores of “grain and animal food pattern” on QoL in Chinese women with early-stage breast cancer over four follow-ups
| EORTC QLQ-C30 | Univariate analysis | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| Global health status/QoL | − 0.691 (− 1.323 to − 0.058) | 0.032 | − 0.349 (− 1.112 to 0.413) | 0.370 | 0.114 (− 0.665 to 0.892) | 0.775 |
| Functioning | ||||||
| Physical functioning | − 0.612 (− 1.021 to − 0.204) | 0.003 | − 0.319 (− 0.838 to 0.200) | 0.228 | − 0.122 (− 0.676 to 0.431) | 0.665 |
| Role functioning | − 1.293 (− 1.852 to − 0.734) | < 0.001 | − 0.891 (− 1.583 to − 0.199) | 0.012 | − 0.744 (− 0.147 to − 0.017) | |
| Emotional functioning | − 1.323 (− 1.978 to − 0.667) | < 0.001 | 0.020 (0.020 to 0.020) | < 0.001 | 0.535 (1.382 to 1.528) | 0.216 |
| Cognitive functioning | − 0.602 (− 1.237 to − 0.033) | 0.063 | 0.423 (0.423 to 0.423) | < 0.001 | 0.720 (− 0.144 to 1.583) | 0.102 |
| Social functioning | − 1.111 (− 1.685 to − 0.536) | < 0.001 | − 0.284 (− 1.001 to 0.432) | 0.436 | − 0.049 (− 0.829 to 0.731) | 0.902 |
| Symptoms | ||||||
| Fatigue | 1.141 (0.435 to 1.847) | 0.002 | − 0.199 (− 1.085 to 0.688) | 0.661 | − 0.491 (− 1.439 to 0.457) | 0.311 |
| Nausea and vomiting | 0.230 (− 0.039 to 0.500) | 0.094 | − 0.050 (− 0.332 to 0.123) | 0.726 | − 0.188 (− 0.513 to 0.137) | 0.256 |
| Pain | 1.486 (0.737 to 2.236) | < 0.001 | 0.543 (− 0.415 to 1.501) | 0.267 | 0.534 (− 0.468 to 1.536) | 0.296 |
| Dyspnea | 1.033 (0.432 to 1.634) | < 0.001 | 0.113 (0.113 to 0.113) | < 0.001 | − 0.092 (− 0.092 to − 0.092) | |
| Insomnia | − 0.147 (− 1.096 to 0.802) | 0.762 | − 0.653 (− 1.821 to 0.514) | 0.273 | − 1.163 (− 2.373 to 0.047) | 0.060 |
| Loss of appetite | 0.319 (− 0.158 to 0.796) | 0.190 | 0.279 (− 0.294 to 0.852) | 0.340 | 0.019 (− 0.617 to 0.654) | 0.954 |
| Constipation | 0.241 (− 0.379 to 0.851) | 0.447 | − 0.623 (− 0.623 to − 0.623) | < 0.001 | − 1.355 (− 2.174 to − 0.536) | |
| Diarrhea | 0.815 (0.384 to 1.246) | < 0.001 | 0.400 (− 0.112 to 0.911) | 0.126 | 0.065 (− 0.498 to 0.627) | 0.822 |
| Financial impact | 1.122 (0.301 to 1.944) | 0.007 | − 0.392 (− 1.266 to 0.481) | 0.379 | − 0.456 (− 1.365 to 0.453) | 0.325 |
GEE models were used to analyze the association of “grain and animal food pattern” and QoL longitudinally over four follow-ups. The potential confounders were introduced in the models using the enter method. Model 1, adjusted for age at follow-up, education level, income status, total number of comorbidities, menopausal status at follow-up, AJCC stage, ER status and PR status, current usage of adjuvant hormonal therapy, BMI at follow-up, level of physical activity at follow-up, total energy intake at follow-up; Model 2, further adjusted for factor scores of “vegetables and fruits pattern”
B Unstandardized coefficient of GEE model, 95%CI 95% confidence interval, QoL quality of life, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, AJCC American joint Committee on cancer, ER estrogen receptor, PR progesterone receptor
Bold face: P < 0.05
GEE models to analyze the factor scores of “vegetables and fruits pattern” on QoL in Chinese women with early-stage breast cancer over four follow-ups
| EORTC QLQ-C30 | Univariate analysis | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| Global health status/QoL | 1.104 (0.400 to 1.807) | 0.002 | 1.251 (0.535 to 1.967) | 0.001 | 1.282 (0.545 to 2.019) | |
| Functioning | ||||||
| Physical functioning | 0.493 (0.033 to 0.953) | 0.036 | 0.578 (0.101 to 1.056) | 0.018 | 0.545 (0.037 to 1.053) | |
| Role functioning | 0.163 (− 0.465 to 0.732) | 0.610 | 0.609 (− 0.065 to 1.282) | 0.077 | 0.406 (− 0.301 to 1.114) | 0.260 |
| Emotional functioning | 0.542 (− 0.159 to 1.243) | 0.130 | 1.282 (0.539 to 2.023) | 0.001 | 1.426 (0.653 to 2.200) | |
| Cognitive functioning | 0.110 (− 0.611 to 0.831) | 0.765 | 0.626 (− 0.129 to 1.382) | 0.104 | 0.822 (0.007 to 1.637) | |
| Social functioning | 0.172 (− 0.457 to 0.801) | 0.591 | 0.666 (0.013 to 1.318) | 0.045 | 0.652 (− 0.054 to 1.358) | 0.070 |
| Symptoms | ||||||
| Fatigue | − 0.181 (− 0.929 to 0.567) | 0.635 | − 0.676 (− 1.454 to 0.102) | 0.088 | − 0.810 (− 1.637 to 0.018) | 0.055 |
| Nausea and vomiting | − 0.255 (− 0.507 to − 0.003) | 0.047 | − 0.331 (− 0.605 to − 0.057) | 0.018 | − 0.382 (− 0.694 to − 0.071) | |
| Pain | 0.382 (− 0.414 to 1.178) | 0.347 | − 0.169 (− 0.998 to 0.661) | 0.690 | − 0.024 (− 0.892 to 0.845) | 0.957 |
| Dyspnea | − 0.043 (− 0.718 to 0.633) | 0.902 | − 0.545 (− 0.545 to − 0.545) | < 0.001 | − 0.570 (− 0.570 to − 0.570) | |
| Insomnia | − 0.672 (− 1.781 to 0.437) | 0.235 | − 1.096 (− 2.287 to 0.095) | 0.071 | − 1.412 (− 2.647 to − 0.177) | |
| Loss of appetite | − 0.668 (− 1.188 to − 0.148) | 0.012 | − 0.727 (− 1.264 to − 0.189) | 0.008 | − 0.722 (− 1.311 to − 0.132) | |
| Constipation | − 1.103 (− 1.797 to − 0.409) | 0.002 | − 1.659 (− 2.372 to 0.947) | < 0.001 | − 2.028 (− 2.775 to − 1.281) | |
| Diarrhea | − 0.590 (− 1.031 to − 0.148) | 0.009 | − 0.946 (− 1.450 to − 0.442) | < 0.001 | − 0.929 (− 1.481 to − 0.377) | |
| Financial impact | 0.625 (− 0.278 to 0.175) | 0.175 | − 0.052 (− 0.939 to 0.834) | 0.908 | − 0.176 (− 1.102 to 0.749) | 0.709 |
GEE models were used to analyze the association of “vegetables and fruits pattern” and QoL longitudinally over four follow-ups. The potential confounders were introduced in the models using the enter method. Model 1, adjusted for age at follow-up, education level, income status, total number of comorbidities, menopausal status at follow-up, AJCC stage, ER status and PR status, current usage of adjuvant hormonal therapy, BMI at follow-up, level of physical activity at follow-up, total energy intake at follow-up; Model 2, further adjusted for factor scores of “grain and animal food pattern”
B Unstandardized coefficient of GEE model, 95%CI 95% confidence interval, QoL quality of life, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30, AJCC American joint Committee on cancer, ER estrogen receptor, PR progesterone receptor
Bold face: P < 0.05